Send this to a friend

Boston Scientific to begin limited release of stroke device

Marlborough medical device maker Boston Scientific said it received the CE Mark for European approval for a stroke-prevention device yet to clear U.S. regulators.
The device is the next generation Watchman FLX Left Atrial Appendage Closure treating patients with atrial fibrillation by reducing the risk of stroke.
The device has already been implanted in more than 75,000 patients worldwide, the company said in a p ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media